These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10219610)

  • 1. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
    Sogni P; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
    Wiest R; Groszmann RJ
    Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of vascular nitric oxide in experimental liver cirrhosis].
    Atucha NM; Nadal FJ; Iyu D; García-Estañ J
    Nefrologia; 2002; 22 Suppl 5():25-8. PubMed ID: 12107913
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
    Martin PY; Ginès P; Schrier RW
    N Engl J Med; 1998 Aug; 339(8):533-41. PubMed ID: 9709047
    [No Abstract]   [Full Text] [Related]  

  • 7. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.
    Rockey D
    Hepatology; 1997 Jan; 25(1):2-5. PubMed ID: 8985256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endothelin, nitric oxide and the control of vascular tone: their physiopathological significance in liver cirrhosis].
    Jiménez W
    Med Clin (Barc); 1995 May; 104(17):671-5. PubMed ID: 7623496
    [No Abstract]   [Full Text] [Related]  

  • 13. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
    Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular endothelium and hypertension with emphasis on NO and endothelins].
    Hirata Y
    Kokyu To Junkan; 1992 Nov; 40(11):1075-84. PubMed ID: 1279772
    [No Abstract]   [Full Text] [Related]  

  • 19. Does altered regulation of ecNOS in sinusoidal endothelial cells determine increased intrahepatic resistance leading to portal hypertension?
    Clemens MG
    Hepatology; 1998 Jun; 27(6):1745-7. PubMed ID: 9620353
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.